Previously, our study revealed that the oncogenic protein Cobll1 is linked to TKI resistance and BC transformation in CML, independent of BCR‐ABL1 expression.13 This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.